LONG-TERM MANAGEMENT AFTER SPLENECTOMY - CONSIDER PROPHYLAXIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:6
作者
DAVIES, KA
BEYNON, HLC
WALPORT, MJ
机构
关键词
D O I
10.1136/bmj.308.6921.133c
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:133 / 133
页数:1
相关论文
共 5 条
[1]   THE ACTUAL SURVIVAL RATE IN SYSTEMIC LUPUS-ERYTHEMATOSUS - STUDY OF A 1976 COHORT [J].
BREBAN, M ;
MEYER, O ;
BOURGEOIS, P ;
PALAZZO, E ;
KAHN, MF .
CLINICAL RHEUMATOLOGY, 1991, 10 (03) :283-288
[2]   MORTALITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - ACTIVE DISEASE IS THE MOST IMPORTANT FACTOR [J].
COHEN, MG ;
LI, EK .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1992, 22 (01) :5-8
[3]  
DAVIES KA, 1993, J IMMUNOL, V151, P3866
[4]   LONG-TERM MANAGEMENT OF PATIENTS AFTER SPLENECTOMY [J].
MCMULLIN, M ;
JOHNSTON, G .
BRITISH MEDICAL JOURNAL, 1993, 307 (6916) :1372-1373
[5]   INCREASED RISK OF NEISSERIAL INFECTIONS IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
MITCHELL, SR ;
NGUYEN, PQ ;
KATZ, P .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1990, 20 (03) :174-184